Latest news

Posts about investor

100× scale-up of NCT production achieved

eXoZymes achieves 100× scale-up of NCT production using exozymes, demonstrating near-perfect feedstock conversion

LA Weekly: The Enzyme Frontier: eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and Pharma

LA Weekly: The Enzyme Frontier - eXoZymes Unlocks a New Era for Cannabinoid Nutraceuticals and Pharma

Slack Capital report

Slack Capital report: EXOZ is a once-in-a-lifetime opportunity

'The Upside' interview: Michael Heltzen & Lou Basenese

'The Upside' interview: Michael Heltzen & Lou Basenese

Transcript: EXOZ Q3 2025 update

EXOZ 2025 Q3 Update

eXoZymes provides third quarter 2025 update at 5PM EST today

CSO Tyler Korman - and Chief of Staff, Amy Lunzer

eXoZymes announces cell-free biomanufacturing pioneer, Tyler Korman, as CSO & Amy Lunzer as Chief of Staff

CSO, Tyler Korman

Co-founder of eXoZymes and cell-free biomanufacturing pioneer, Tyler Korman, speaks to his new role as CSO

CEO, Michael Heltzen is interviewed by Jane King

Jane King interviews CEO, Michael Heltzen, in New York

2025 Q3 Earnings Call

eXoZymes to host third quarter 2025 update on Thursday November 13, 2025, at 5PM EST